With a robust background in venture capital, the fund manager has successfully executed over 30 deals across technology and healthcare sectors, primarily in North America and Europe. Their strategic focus leans toward early-stage investments, emphasizing a data-driven approach that prioritizes scalability and innovation. Notable exits demonstrate a strong track record of generating returns, reflecting an operator-first style that fosters close collaboration with portfolio companies. Their expertise in thematic investing has consistently targeted disruptive trends, positioning them as a key player in the evolving market landscape.